Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT00874497 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

EMPHASIS
Start date: March 2009
Phase: Phase 2
Study type: Interventional

Phase 2a multicenter, randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, efficacy, and safety of tetomilast in patients with emphysema.

NCT ID: NCT00846573 Terminated - Healthy Clinical Trials

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.

NCT ID: NCT00826748 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Effect of Inhaled Steroids on Gene Expression in the Lungs - 2

Start date: November 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effect of inhaled beclomethasone (an inhaled corticosteroid) on the pattern of the lung airway epithelium and alveolar macrophages gene expression of healthy smokers. We hypothesize that the administration of beclomethasone will result in reversibility of some of the airway epithelium and alveolar macrophage gene expression changes induced by cigarette smoking.

NCT ID: NCT00783250 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients

Start date: September 2008
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess the effects on respiratory mechanics of one "classical" short-term bronchodilator (i.e., salbutamol) versus placebo, and to verify the hypothesis that the addition of another bronchodilator (i.e., anticholinergic) may induce a further improvement on the work of breathing of stable COPD patients.

NCT ID: NCT00763035 Terminated - Asthma Clinical Trials

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

Start date: January 2009
Phase: Early Phase 1
Study type: Interventional

The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups.

NCT ID: NCT00751309 Terminated - Lung Disease Clinical Trials

Lung Allograft Rejection Gene Expression Observational (LARGO) Study

LARGO
Start date: April 2004
Phase: N/A
Study type: Observational

The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular analyses in association with the study endpoints. The primary objective is to use gene expression profiling of peripheral blood mononuclear cells to differentiate between the absence and presence of acute cellular rejection. The secondary objectives are to use other genomic and proteomic technologies to analyze RNA and protein in blood samples in relation to related clinical conditions. The overall goal is to apply novel molecular insights in the development of non-invasive molecular diagnostic tests for lung transplantation.

NCT ID: NCT00747461 Terminated - Sarcoidosis Clinical Trials

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")

ICEtheBAD
Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)

NCT ID: NCT00744614 Terminated - Asthma Clinical Trials

Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients

Start date: November 2007
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the use of Capnography (Continuous recording of the carbon dioxide content of expired air)as an alternative test to measure PC02 levels in patients with asthma, chronic obstructive pulmonary (COPD,interstitial lung disease(ILD)or coronary disease who are at risk of intubation.

NCT ID: NCT00710541 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD)

Start date: October 2004
Phase: N/A
Study type: Interventional

Non-invasive ventilation is frequently applied in patients with acute exacerbation of COPD, but no evidence exists about the effect of long term application/home application. This study tests the hypothesis, that a daily, 6 hour application of non-invasive ventilation over one year improves survival, exercise capacity, and quality of life in patients with advanced stages of COPD.

NCT ID: NCT00706914 Terminated - Clinical trials for Pulmonary Disease, Chronic Obstructive

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Start date: June 30, 2008
Phase: Phase 2
Study type: Interventional

This exploratory study will compare the efficacy of the fixed-dose combination (FDC) of aclidinium bromide and formoterol fumarate once daily in the morning and placebo once in the evening vs. the FDC once daily in the morning and formoterol fumarate once in the evening vs. formoterol fumarate twice daily. The study will assess pulmonary function and symptoms in patients with moderate to severe COPD.